Advertisement
Screener

Protalix BioTherapeutics, Inc. (PLX) Patents: Active

Protalix BioTherapeutics, Inc. Active Patents

12 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-02-01: Application 18429649; Invention METHODS OF TREATING DISEASES ASSOCIATED WITH ELEVATED URIC ACID; Applicant Protalix Ltd.; Status Patented Case.
  • 2023-05-03: Application 18035149; Invention MODIFIED URICASE AND USES THEREOF; Applicant Protalix Ltd.; Status Patented Case.
  • 2022-05-18: Application 17777669; Invention REMOVAL OF CONSTRUCTS FROM TRANSFORMED CELLS; Applicant Protalix Ltd.; Status Patented Case.
  • 2022-04-08: Application 17716348; Invention STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF; Applicant Protalix Ltd.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-02-0118429649METHODS OF TREATING DISEASES ASSOCIATED WITH ELEVATED URIC ACIDProtalix Ltd.Patented Case2026-08-1112703857US20240263150A1
Ilya RUDERFER
Yakir NATAF
Gil ARVATZ
Uri HANANIA
Tamar ARIEL
Shelly ROZEN
Yael HAYON
Zohar KEREN
Orit COHEN-BARAK
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
YAMASAKI, ROBERT J
2023-05-0318035149MODIFIED URICASE AND USES THEREOFProtalix Ltd.Patented Case2026-07-0712674146US20240002814A1
Ilya RUDERFER
Yakir NATAF
Gil ARVATZ
Uri HANANIA
Tamar ARIEL
Shelly ROZEN
Yael HAYON
Israel
Israel
Israel
Israel
Israel
Israel
Israel
KANE, TREVOR LOGAN
2022-05-1817777669REMOVAL OF CONSTRUCTS FROM TRANSFORMED CELLSProtalix Ltd.Patented Case2025-08-1212385054US20230022576A1
Maor SHEVA
Uri HANANIA
Israel
Israel
FAN, WEIHUA
2022-04-0817716348STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOFProtalix Ltd.Patented Case2025-08-1212385026US20230074255A1
Avidor Shulman
Ilya Ruderfer
Tehila Ben-Moshe
Talia Shekhter
Yaniv Azulay
Tali Kizhner
Yoseph Shaaltiel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
RAGHU, GANAPATHIRAM
2021-12-2017555557MODIFIED DNASE AND USES THEREOFProtalix Ltd.Patented Case2023-11-1411814657US20220106578A1
Lilach CHEN ZELTSBURG
Ilya RUDERFER
Avidor SHULMAN
Liat FUX
Yulia UGORTSEV
Hagit NETA
Sivan GELLEY
Elad LAVEE LAVIAD
Yoseph SHAALTIEL
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
SAIDHA, TEKCHAND
2019-07-0416476084THERAPEUTIC REGIMEN FOR THE TREATMENT OF FABRY USING STABILIZED ALPHA-GALACTOSIDASEProtalix Ltd.Patented Case2025-01-1412194079US20200155654A1
Einat ALMON
Raul CHERTKOFF
Sari ALON
Yoseph SHAALTIEL
Israel
Israel
Israel
Israel
TSAY, MARSHA M
2019-03-1816356238STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOFProtalix Ltd.Patented Case2020-12-2210870842US20190256832A1
Avidor Shulman
Ilya Ruderfer
Tehila Ben-Moshe
Talia Shekhter
Yaniv Azulay
Tali Kizhner
Yoseph Shaaltiel
Israel
Israel
Israel
Israel
Israel
Israel
Israel
RAGHU, GANAPATHIRAM
2017-06-2915636753STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOFProtalix Ltd.Patented Case2019-05-0710280414US20180148703A1
Avidor SHULMAN
Ilya RUDERFER
Tehila BEN-MOSHE
Talia SHEKHTER
Yaniv AZULAY
Tali KIZHNER
Yoseph SHAALTIEL
Israel
Israel
Israel
Israel
Israel
Israel
Israel
RAGHU, GANAPATHIRAM
2015-11-1014936720STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOFProtalix Ltd.Patented Case2017-07-189708595US20160053247A1
Avidor SHULMAN
Ilya RUDERFER
Tehila BEN-MOSHE
Talia SHEKHTER
Yaniv AZULAY
Tali KIZHNER
Yoseph SHAALTIEL
Israel
Israel
Israel
Israel
Israel
Israel
Israel
RAGHU, GANAPATHIRAM
2014-07-3014375485DRY POWDER FORMULATIONS OF DNASE IProtalix Ltd.Patented Case2017-03-289603907US20150024050A1
Yoseph Shaaltiel
Uri Hanania
Tali Kizhner
Yulia Matiuhin
Liat Fux
Avidor Shulman
Israel
Israel
Israel
Israel
Israel
Israel
NOAKES, SUZANNE MARIE
2014-07-3014375439INHALABLE LIQUID FORMULATIONS OF DNASE IProtalix Ltd.Patented Case2017-03-289603906US20150010617A1
Yoseph Shaaltiel
Uri Hanania
Tali Kizhner
Yulia Matiuhin
Liat Fux
Avidor Shulman
Israel
Israel
Israel
Israel
Israel
Israel
NOAKES, SUZANNE MARIE
2014-06-0214292966PLANT CELL CULTURE EXPRESSING HUMAN LYSOSOMAL PROTEINS AND USES THEREOFProtalix Ltd.Patented Case2015-12-299220737US20140271577A1
Yoseph SHAALTIEL
Gideon Baum
Daniel Bartfeld
Sharon Hashmueli
Ayala Lewkowicz
Israel
Israel
Israel
Israel
Israel
FRONDA, CHRISTIAN L

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95